Concepedia
Statistics
Publications
15
Citations
1.3K
H-Index
14
Active since
1997
Affiliations
Hammersmith Hospital(Current)
Mount Vernon Hospital
Yale University
Leipzig University
Imperial College London
David R. Collingridge is an author at Hammersmith Hospital specializing in medicine, oncology, and tumor oxygenation.
Publications per year
1997–2006
3'-deoxy-3'-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography.
Henryk Barthel, Marcel Cleij, David R. Collingridge et al. · PubMed · 2003 · 273 citations
Medicine, Nuclear Medicine, Oncology +17
Polarographic measurements of oxygen tension in human glioma and surrounding peritumoural brain tissue
David R. Collingridge, Joseph M. Piepmeier, Sara Rockwell et al. · Radiotherapy and Oncology · 1999 · 161 citations · Full text
Medicine, Neuroscience, Neurosurgery +16
The development of [(124)I]iodinated-VG76e: a novel tracer for imaging vascular endothelial growth factor in vivo using positron emission tomography.
David R. Collingridge, Veronica A. Carroll, Mathias Glaser et al. · PubMed · 2002 · 154 citations
In vivo evaluation of [18F]fluoroetanidazole as a new marker for imaging tumour hypoxia with positron emission tomography
Henryk Barthel, H. F. Wilson, David R. Collingridge et al. · British Journal of Cancer · 2004 · 92 citations · Full text
Measurement of Tumor Oxygenation: A Comparison between Polarographic Needle Electrodes and a Time-Resolved Luminescence-Based Optical Sensor
David R. Collingridge, William K. Young, Borivoj Vojnovic et al. · Radiation Research · 1997 · 87 citations
Engineering, Biomedical Engineering, Oncology +17
1–5 of 15